Unifiram.
Potent AMPA modulator similar to sunifiram A lab-made compound from the racetam family, studied in animals as an AMPA receptor modulator. What it does in people has not been measured and published.
Reviewed March 2026
- Category
- Nootropic
- Also filed under
- AMPA ModulationMemoryFocus
What Unifiram is, and what it does.
- Does it work
- Suits people who follow experimental nootropic chemistry closely and understand the human record is not there yet. Anyone who wants a documented human profile is looking at a different compound.
- How much to take
- Start at the bottom of the 1mg to 5mg a day band. That band comes from practice, since no published human dose-ranging study exists for it.
- Time to feel it
- Nobody has measured this in people. No human pharmacokinetic study describes its onset, so every timeline in circulation is self-report rather than data.
- The first dose
- Day one is undocumented in the literature. Users describe same-day effects, and no published human study records what actually happens in that first day.
- With regular use
- Most effects take 2-8 weeks. Be patient.
- How well tolerated
- Generally well tolerated. Check with your doctor if on medications.
- How it feels
- User reports claim strong effects but no safety data
- The overlooked benefit
- The choline pairing convention it inherited from the racetams describes what formulators do. No published evidence shows unifiram itself works through acetylcholine.
1 to 5mg a day is where Unifiram works.
Source: Galeotti et al. (2003) Behav Brain Res; animal studies only
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Unifiram has emerging evidence. Based on 11+ studies.
- AMPA receptor modulationAnimal study
- memory task performance in rodentsAnimal study
- the choline-donor pairing rationale carried over from the racetam classNarrative review
Questions people ask about Unifiram.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Unifiram-class compounds have been reported in rodent hippocampal tissue to increase acetylcholine release, which draws on the free choline pool. Alpha-GPC crosses into the brain and donates choline directly, refilling the precursor that release spends.
Citicoline is cleaved to choline and cytidine, feeding acetylcholine synthesis and membrane phosphatidylcholine turnover. Paired with a compound reported to increase cholinergic release, it keeps precursor supply matched to demand.
Choline acetyltransferase makes acetylcholine from choline and acetyl-CoA, so acetylcholine release depends on available choline. Adequate dietary or supplemental choline is the upstream half of that step.
Caffeine appears alongside almost every nootropic sold, and the pairing here rests on that practice rather than on any measured interaction. Unifiram has no published human pharmacokinetic profile, so nothing is known about how the two behave together. The honest label is early and the row is page-only.
The acetyl side of acetylcholine synthesis comes from acetyl-CoA, and acetyl-L-carnitine can contribute acetyl groups, which is settled biochemistry. Applying that to unifiram assumes a cholinergic mechanism that has not been demonstrated in humans. The biochemistry is real, the relevance here is speculative.
Phosphatidylserine is a membrane phospholipid with its own cognitive literature and is routinely stacked with nootropics. Nothing connects it to unifiram specifically. It sits here as a category convention.
Bacopa has a human literature of its own on memory measures over multi-week dosing. Unifiram does not. Combining them is a stack decision, not an evidenced pairing, and the two have very different evidence footings.
Nothing specific on file for Unifiram. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Unifiram actually does.
No published human pharmacokinetic, dose-ranging or safety data describe unifiram, so no oral dose, half-life or exposure profile in people can be stated from the literature.
Pairing a nootropic with a choline donor such as alpha-GPC or citicoline is a formulation convention inherited from the racetam class, where the rationale is supplying substrate for acetylcholine synthesis; the convention describes what formulators do and does not establish that unifiram acts cholinergically.
Choline is the rate-limiting substrate for acetylcholine synthesis by choline acetyltransferase, which is the settled biochemistry behind every choline-donor pairing regardless of what it is paired with.
Where Unifiram comes from.
This one is made in a chemistry lab from scratch. There is no plant, no mushroom and no fermentation behind it. There is also no official standard that says what pure unifiram must look like on a test, so what you get depends entirely on who made it and what they chose to test.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
A fully synthetic small molecule built from commodity organic intermediates. It has no botanical, animal or fermentation source.
Produced by ordinary synthetic organic chemistry. Specific published commercial routes are not available in the public literature the way they are for compendial ingredients.
Standard purification for a research chemical. What was actually done, and to what specification, is set by the individual supplier.
Supplied as powder. There is no pharmacopoeial monograph defining identity, assay limits or impurity thresholds, so specifications are supplier-defined rather than compendial.
Synthetic route, impurity profile and specification are supplier-defined and generally not published.
Getting Unifiram from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.